Mark Canter

Mark Canter is a seasoned professional in the biotechnology field with extensive experience spanning over two decades. Currently serving as the Director of Biotechnology at DPS Group Global since September 2021, Mark previously held the position of Biopharma Process Director at Jacobs from June 2015 to September 2021. Mark also has a significant tenure at Stantec as Principal, focusing on biopharmaceutical practice from March 2012 to June 2015. Prior roles include Vice President of West Coast Operations at Biokinetics, where Mark worked from September 2008 to March 2012, and Team Leader at Biokinetics from 1999 to 2008. Earlier in the career, Mark was Engineering Manager at Unigene Laboratories and Director of Bioprocess Equipment at New Brunswick Scientific. Mark holds a degree from Cornell University, obtained between 1976 and 1980.